Laporan Laba Rugi (TTM)
Laporan Laba Rugi Ahn-Gook Pharmaceutical Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 156,318 | 143,364 | 141,126 | 143,734 | 149,137 | 163,534 | 175,163 | 182,760 | 195,740 | 205,388 | 213,414 | 224,219 | 226,186 | 233,676 | 244,223 | 252,480 | 264,636 | 271,116 | 281,128 | 290,775 |
| Change (%) | -8.29 | -1.56 | 1.85 | 3.76 | 9.65 | 7.11 | 4.34 | 7.10 | 4.93 | 3.91 | 5.06 | 0.88 | 3.31 | 4.51 | 3.38 | 4.81 | 2.45 | 3.69 | 3.43 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 52,853 | 58,471 | 57,025 | 58,286 | 59,473 | 62,516 | 67,849 | 70,574 | 75,199 | 79,109 | 80,640 | 85,173 | 86,870 | 93,105 | 99,411 | 100,810 | 105,196 | 103,219 | 104,106 | 106,113 |
| Change (%) | 10.63 | -2.47 | 2.21 | 2.04 | 5.12 | 8.53 | 4.02 | 6.55 | 5.20 | 1.93 | 5.62 | 1.99 | 7.18 | 6.77 | 1.41 | 4.35 | -1.88 | 0.86 | 1.93 | |
| % of Revenue | 33.81 | 40.79 | 40.41 | 40.55 | 39.88 | 38.23 | 38.74 | 38.62 | 38.42 | 38.52 | 37.79 | 37.99 | 38.41 | 39.84 | 40.71 | 39.93 | 39.75 | 38.07 | 37.03 | 36.49 |
| Gross Operating Profit | 103,465 | 84,893 | 84,101 | 85,449 | 89,664 | 101,018 | 107,314 | 112,186 | 120,541 | 126,280 | 132,774 | 139,046 | 139,316 | 140,571 | 144,811 | 151,669 | 159,440 | 167,896 | 177,022 | 184,661 |
| Change (%) | -17.95 | -0.93 | 1.60 | 4.93 | 12.66 | 6.23 | 4.54 | 7.45 | 4.76 | 5.14 | 4.72 | 0.19 | 0.90 | 3.02 | 4.74 | 5.12 | 5.30 | 5.44 | 4.32 | |
| % of Revenue | 66.19 | 59.22 | 59.59 | 59.45 | 60.12 | 61.77 | 61.26 | 61.38 | 61.58 | 61.48 | 62.21 | 62.01 | 61.59 | 60.16 | 59.29 | 60.07 | 60.25 | 61.93 | 62.97 | 63.51 |
| SG&A | 68,856 | 66,046 | 65,993 | 70,046 | 72,662 | 83,329 | 91,384 | 94,842 | 100,579 | 102,477 | 106,305 | 113,498 | 118,675 | 122,101 | 127,189 | 132,542 | 138,951 | 145,370 | 149,554 | 151,344 |
| Change (%) | -4.08 | -0.08 | 6.14 | 3.73 | 14.68 | 9.67 | 3.78 | 6.05 | 1.89 | 3.74 | 6.77 | 4.56 | 2.89 | 4.17 | 4.21 | 4.84 | 4.62 | 2.88 | 1.20 | |
| % of Revenue | 44.05 | 46.07 | 46.76 | 48.73 | 48.72 | 50.96 | 52.17 | 51.89 | 51.38 | 49.89 | 49.81 | 50.62 | 52.47 | 52.25 | 52.08 | 52.50 | 52.51 | 53.62 | 53.20 | 52.05 |
| R&D | 28,013 | 16,993 | 17,405 | 17,789 | 17,768 | 17,328 | 15,523 | 13,243 | 12,613 | 12,957 | 13,384 | 13,290 | 13,045 | 12,255 | 12,124 | 12,334 | 12,256 | 13,260 | 14,936 | 17,331 |
| Change (%) | -39.34 | 2.42 | 2.21 | -0.12 | -2.48 | -10.42 | -14.69 | -4.76 | 2.72 | 3.30 | -0.70 | -1.85 | -6.06 | -1.07 | 1.73 | -0.63 | 8.19 | 12.64 | 16.04 | |
| % of Revenue | 17.92 | 11.85 | 12.33 | 12.38 | 11.91 | 10.60 | 8.86 | 7.25 | 6.44 | 6.31 | 6.27 | 5.93 | 5.77 | 5.24 | 4.96 | 4.89 | 4.63 | 4.89 | 5.31 | 5.96 |
| OpEx | 151,359 | 143,413 | 142,465 | 147,394 | 151,442 | 164,618 | 176,161 | 180,074 | 189,818 | 196,008 | 201,756 | 213,288 | 219,830 | 228,614 | 239,829 | 247,081 | 258,512 | 264,438 | 271,658 | 278,025 |
| Change (%) | -5.25 | -0.66 | 3.46 | 2.75 | 8.70 | 7.01 | 2.22 | 5.41 | 3.26 | 2.93 | 5.72 | 3.07 | 4.00 | 4.91 | 3.02 | 4.63 | 2.29 | 2.73 | 2.34 | |
| % of Revenue | 96.83 | 100.03 | 100.95 | 102.55 | 101.55 | 100.66 | 100.57 | 98.53 | 96.97 | 95.43 | 94.54 | 95.12 | 97.19 | 97.83 | 98.20 | 97.86 | 97.69 | 97.54 | 96.63 | 95.62 |
| Operating Income | 4,960 | -49 | -1,339 | -3,659 | -2,305 | -1,084 | -998 | 2,686 | 5,922 | 9,381 | 11,658 | 10,931 | 6,357 | 5,061 | 4,394 | 5,399 | 6,124 | 6,678 | 9,470 | 12,749 |
| Change (%) | -100.99 | 2,626.10 | 173.36 | -37.01 | -52.97 | -7.98 | -369.22 | 120.49 | 58.41 | 24.28 | -6.24 | -41.85 | -20.37 | -13.19 | 22.87 | 13.44 | 9.04 | 41.82 | 34.62 | |
| % of Revenue | 3.17 | -0.03 | -0.95 | -2.55 | -1.55 | -0.66 | -0.57 | 1.47 | 3.03 | 4.57 | 5.46 | 4.88 | 2.81 | 2.17 | 1.80 | 2.14 | 2.31 | 2.46 | 3.37 | 4.38 |
| Interest Expense | -1,267 | -757 | -579 | -287 | -145 | -117 | -59 | -126 | -133 | -160 | -180 | -181 | -163 | -143 | -632 | -1,416 | -2,212 | -3,002 | -3,211 | -3,090 |
| Change (%) | -40.27 | -23.46 | -50.40 | -49.51 | -19.48 | -49.75 | 115.04 | 5.67 | 20.23 | 12.11 | 0.48 | -9.59 | -12.62 | 342.87 | 123.94 | 56.24 | 35.74 | 6.95 | -3.78 | |
| % of Revenue | -0.81 | -0.53 | -0.41 | -0.20 | -0.10 | -0.07 | -0.03 | -0.07 | -0.07 | -0.08 | -0.08 | -0.08 | -0.07 | -0.06 | -0.26 | -0.56 | -0.84 | -1.11 | -1.14 | -1.06 |
| Net Income | -1,003 | -1,315 | -2,505 | 242 | 1,391 | 3,939 | 4,077 | 7,005 | 9,471 | 6,875 | 8,298 | 7,801 | 4,581 | 1,290 | 6,406 | 15,349 | 14,281 | 16,845 | 12,632 | 6,103 |
| Change (%) | 31.19 | 90.44 | -109.66 | 474.55 | 183.21 | 3.51 | 71.80 | 35.20 | -27.41 | 20.70 | -6.00 | -41.27 | -71.84 | 396.54 | 139.61 | -6.96 | 17.95 | -25.01 | -51.68 | |
| % of Revenue | -0.64 | -0.92 | -1.78 | 0.17 | 0.93 | 2.41 | 2.33 | 3.83 | 4.84 | 3.35 | 3.89 | 3.48 | 2.03 | 0.55 | 2.62 | 6.08 | 5.40 | 6.21 | 4.49 | 2.10 |
Source: Capital IQ
